Verified Nov 2026
Batteries & E-Mobility
·

Shenzhen, Guangdong
·
Since 1998
Hepalink Group is a biopharmaceutical company headquartered in Shenzhen, China, founded in 1998. The company employs 1,000–5,000 people and generates estimated revenue of $500M–$1B. It operates across pharmaceutical manufacturing, contract development and manufacturing services, and drug development for automotive, electric-vehicle, medical, and industrial-equipment sectors. The company produces heparin-related APIs and injections, including enoxaparin sodium, and operates GMP-compliant facilities in China and the United States.
Hepalink Group at a glance
Revenue
$500M-1B
Est. band
Employees
1,000-5,000
Founded
1998
Headquarters
Shenzhen, Guangdong
Industries
Automotive
Electric Vehicles
Medical
Industrial Equipment
Overview
Hepalink Group is a biopharmaceutical company headquartered in Shenzhen, China, founded in 1998. The company employs 1,000–5,000 people and generates estimated revenue of $500M–$1B. It operates across pharmaceutical manufacturing, contract development and manufacturing services, and drug development for automotive, electric-vehicle, medical, and industrial-equipment sectors. The company produces heparin-related APIs and injections, including enoxaparin sodium, and operates GMP-compliant facilities in China and the United States.
At a glance
Attribute | Detail |
|---|---|
Founded | 1998 |
Headquarters | Shenzhen, Guangdong |
Employees | 1,000-5,000 |
Revenue | $500M-1B (estimated) |
Primary capability | Batteries & E-Mobility |
What Hepalink Group makes
The company offers large-molecule biologics CDMO services including process development, analytical testing, formulation research, and mammalian cell culture production for pharmaceutical intermediates and APIs.
Latest developments
2026-04-21 — Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (hepalink.com)
2025-01-03 — Shenzhen Hepalink Pharmaceuticals to Distribute Gabapentin in US under New Agreement - Insight, China's Pharmaceutical Industry (flcube.com)
Company details
Hepalink is dual-listed in Hong Kong and mainland China and serves international pharmaceutical companies across Europe, the United States, Turkey, and Brazil. Hepalink Group was founded in 1998, has an estimated 1,000-5,000 employees, and is headquartered in Shenzhen, Guangdong.
Frequently asked questions
What does Hepalink Group make?
Hepalink Group is a biopharmaceutical company headquartered in Shenzhen, China, founded in 1998. The company employs 1,000–5,000 people and generates estimated revenue of $500M–$1B. It operates across pharmaceutical manufacturing, contract development and manufacturing services, and drug development for automotive, electric-vehicle, medical, and industrial-equipment sectors. The company produces heparin-related APIs and injections, including enoxaparin sodium, and operates GMP-compliant facilities in China and the United States.
Where is Hepalink Group headquartered?
Hepalink Group is headquartered in Shenzhen, Guangdong.
When was Hepalink Group founded?
Hepalink Group was founded in 1998.
How big is Hepalink Group?
Hepalink Group has an estimated 1,000-5,000 employees, with revenue in the $500M-1B range (estimated).
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.
